Literature DB >> 21057241

A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.

Alasdair M Barr, William G Honer, Joy L Johnson, Tony K Y Wu, Ric M Procyshyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21057241     DOI： 10.1097/JCP.0b013e3181fab7ca

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  Altered amygdala connectivity within the social brain in schizophrenia.

Authors:  Prerona Mukherjee; Heather C Whalley; James W McKirdy; Reiner Sprengelmeyer; Andrew W Young; Andrew M McIntosh; Stephen M Lawrie; Jeremy Hall
Journal:  Schizophr Bull       Date:  2013-07-12       Impact factor: 9.306

Review 2.  Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.

Authors:  David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

3.  Current perspectives on chlorpromazine equivalents: Comparing apples and oranges!

Authors:  Vijay Danivas; Ganesan Venkatasubramanian
Journal:  Indian J Psychiatry       Date:  2013-04       Impact factor: 1.759

4.  Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data.

Authors:  Michael Bauer; Tasha Glenn; Martin Alda; Kemal Sagduyu; Wendy Marsh; Paul Grof; Rodrigo Munoz; Emanuel Severus; Philipp Ritter; Peter C Whybrow
Journal:  Int J Bipolar Disord       Date:  2013-05-03

5.  Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.

Authors:  Lik Hang N Lee; Ric M Procyshyn; Randall F White; Todd S Woodward; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

6.  Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.

Authors:  Heidi N Boyda; Ric M Procyshyn; Catherine C Y Pang; Erin Hawkes; Daniel Wong; Chen Helen Jin; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.